Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Tourmaline Bio Inc.

TRML
Current price
25.36 USD -1.47 USD (-5.48%)
Last closed 26.26 USD
Company
ISIN unknown
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 737 481 152 USD
Yield for 12 month +53.88 %
1Y
3Y
5Y
10Y
15Y
TRML
21.11.2021 - 28.11.2021

Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune and inflammatory diseases. It develops TOUR006, a human anti-IL-6 monoclonal antibody that selectively binds to interleukin-6, a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The company's development pipeline comprises medicines and therapies for the atherosclerotic cardiovascular disease (ASCVD) and thyroid eye disease (TED). The company was formerly known as Tourmaline Bio, LLC and changed its name to Tourmaline Bio, Inc. in September 2022. Tourmaline Bio, Inc. was founded in 2021 and is headquartered in New York, New York. Address: 27 West 24th Street, New York, NY, United States, 10010

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

58.33 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-33 000 USD

Last Year

-6 000 USD

Current Quarter

Last Quarter

-10 000 USD

Key Figures TRML

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -78 775 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -23.82 %
PEG Ratio
Return On Equity TTM -31.82 %
Wall Street Target Price 58.33 USD
Revenue TTM
Book Value 12.52 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -1.92 USD
Diluted Eps TTM -1.92 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics TRML

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

-3581 %

Dividend History TRML

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:10
Payout Ratio
Last Split Date 20.10.2023
Dividend Date 20.10.2023

Stock Valuation TRML

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -281.9522
Price Book MRQ 2.1801

Financials TRML

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators TRML

For 52 weeks

12.12 USD 48.31 USD
50 Day MA 24.21 USD
Shares Short Prior Month 1 895 044
200 Day MA 22.45 USD
Short Ratio 4.76
Shares Short 1 517 191
Short Percent 6.64 %